Selective fragmentation of the trans-Golgi apparatus by Rickettsia rickettsii

Fragmentation of the Golgi apparatus is observed during a number of physiological processes including mitosis and apoptosis, but also occurs in pathological states such as neurodegenerative diseases and some infectious diseases. Here we show that highly virulent strains of Rickettsia rickettsii, the causative agent of Rocky Mountain spotted fever, induce selective fragmentation of the trans-Golgi network (TGN) soon after infection of host cells by secretion of the effector protein Rickettsial Ankyrin Repeat Protein 2 (RARP2). Remarkably, this fragmentation is pronounced for the trans-Golgi network but the cis-Golgi remains largely intact and appropriately localized. Thus R. rickettsii targets specifically the TGN and not the entire Golgi apparatus. Dispersal of the TGN is mediated by the secreted effector protein RARP2, a recently identified type IV secreted effector that is a member of the clan CD cysteine proteases. Site-directed mutagenesis of a predicted cysteine protease active site in RARP2 prevents TGN disruption. General protein transport to the cell surface is severely impacted in cells infected with virulent strains of R. rickettsii. These findings suggest a novel manipulation of cellular organization by an obligate intracellular bacterium to determine interactions with the host cell.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:16

Enthalten in:

PLoS pathogens - 16(2020), 5 vom: 18. Mai, Seite e1008582

Sprache:

Englisch

Beteiligte Personen:

Aistleitner, Karin [VerfasserIn]
Clark, Tina [VerfasserIn]
Dooley, Cheryl [VerfasserIn]
Hackstadt, Ted [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Research Support, N.I.H., Intramural

Anmerkungen:

Date Completed 21.07.2020

Date Revised 21.07.2020

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.ppat.1008582

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM310043581